However, while considering specific gene mutations, we found there was a trend that cases of EBV infection had more frequent CORO1A mutations than the rest of our cohort [3/52 [6.4%] vs. 0/60 [0.0%], OR 8.556, 95% CI: 0.4313–169.7, p = 0.0970], which suggested that CORO1A mutation may lead to an increased risk of EBV infection. Here, CORO1A is linked to Epstein-Barr virus infection.